PE20211448A1 - Procesos e intermedios para preparar un medicamento - Google Patents
Procesos e intermedios para preparar un medicamentoInfo
- Publication number
- PE20211448A1 PE20211448A1 PE2020001350A PE2020001350A PE20211448A1 PE 20211448 A1 PE20211448 A1 PE 20211448A1 PE 2020001350 A PE2020001350 A PE 2020001350A PE 2020001350 A PE2020001350 A PE 2020001350A PE 20211448 A1 PE20211448 A1 PE 20211448A1
- Authority
- PE
- Peru
- Prior art keywords
- compound
- medication
- intermediates
- prepare
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361786842P | 2013-03-15 | 2013-03-15 | |
EP13159470 | 2013-03-15 | ||
EP13197813 | 2013-12-17 | ||
PCT/EP2014/054621 WO2014139970A1 (en) | 2013-03-15 | 2014-03-11 | Processes and intermediates for preparing a medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20211448A1 true PE20211448A1 (es) | 2021-08-05 |
Family
ID=50239639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2020001350A PE20211448A1 (es) | 2013-03-15 | 2014-03-11 | Procesos e intermedios para preparar un medicamento |
Country Status (5)
Country | Link |
---|---|
CL (1) | CL2015002668A1 (zh) |
HK (1) | HK1216178A1 (zh) |
IL (1) | IL240533A0 (zh) |
PE (1) | PE20211448A1 (zh) |
PH (1) | PH12015502000A1 (zh) |
-
2014
- 2014-03-11 PE PE2020001350A patent/PE20211448A1/es unknown
-
2015
- 2015-08-12 IL IL240533A patent/IL240533A0/en active IP Right Review Request
- 2015-09-08 PH PH12015502000A patent/PH12015502000A1/en unknown
- 2015-09-14 CL CL2015002668A patent/CL2015002668A1/es unknown
-
2016
- 2016-04-13 HK HK16104203.7A patent/HK1216178A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NZ711026A (en) | 2021-01-29 |
CL2015002668A1 (es) | 2016-03-04 |
PH12015502000A1 (en) | 2016-01-11 |
HK1216178A1 (zh) | 2016-10-21 |
IL240533A0 (en) | 2015-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018000589A2 (es) | Oxiesteroles y composiciones farmacéuticas que los contienen | |
BR112017024917A2 (pt) | síntese de compostos heterocíclicos | |
GT201600085A (es) | Composiciones y métodos para modular los receptores x farnesoides | |
CO2018000660A2 (es) | Compuestos derivados del (3β)-cholest-5-en-3-alquil-3-ol y (3β)-cholest-3-alquil-3-ol | |
AR103680A1 (es) | Inhibidores selectivos de bace1 | |
SV2016005351A (es) | Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble | |
BR112017010354A2 (pt) | compostos de triazolopirimidina e usos dos mesmos | |
MD3313817T2 (ro) | Derivați biciclici, un procedeu pentru prepararea lor și compozițiile farmaceutice care îi conțin | |
CU20180073A7 (es) | Nuevos derivados de amonio, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
UY35362A (es) | Compuestos terapéuticos | |
ECSP15008851A (es) | Compuestos heteroaromáticos como inhibidores de btk | |
EA201491362A1 (ru) | Анестезирующие соединения и способы их применения | |
CL2013002417A1 (es) | Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas. | |
CR20160291A (es) | Análogos de cortistatina y síntesis y usos de los mismos | |
ECSP12011799A (es) | Compuestos de espiropiperidina y uso farmacéutico de los mismos | |
BR112013031493A2 (pt) | composto, composição farmacêutica, uso de um composto, combinação de um composto, dispositivo e processo de preparação de um composto. | |
EA201591805A1 (ru) | Оксабицикло [2.2.2] кислоты - модуляторы gpr120 | |
MX2015001246A (es) | Ibrutinib deuterado. | |
AR087451A1 (es) | Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes | |
PH12016501462A1 (en) | Neprilysin inhibitors | |
NI201800071A (es) | Compuestos de isoindol | |
EA201592268A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 | |
BR112017000730B8 (pt) | Derivados de pirrolidinona como inibidores de metap-2, e medicamentos | |
MY181641A (en) | Amino pyran ring derivative and composition and use thereof | |
GT201400167A (es) | Nuevos derivados de bencil sulfonamida utiles como inhibidores de mogat-2 |